Professional Documents
Culture Documents
DOI 10.1007/s00421-007-0669-3
O R I G I N A L A R T I CL E
Introduction
Despite well documented beneWcial eVects of creatine supplementation on exercise performance, neurodegenerative
disorders, musculoskeletal abnormalities and mitochondrial
cytopathies (Terjung et al. 2000), several case reports have
suggested that supplementation may impair renal function
(Kuehl et al. 1998; Pritchard and Kalra 1998; Koshy et al.
1999; Thorsteinsdottir et al. 2006). In addition, recent Wndings have demonstrated creatine-induced deleterious eVects
in rats with cystic kidney disease (Edmunds et al. 2001) and
sedentary animals (Ferreira et al. 2005). In contrast, other
studies have indicated no deleterious eVect in sedentary
(Taes et al. 2003) or exercised (Ferreira et al. 2005) rats,
and in pre-existing renal failure rats (Taes et al. 2003).
Studies in humans have indicated that creatine supplementation does not aVect renal function (Poortmans et al. 1997;
Poortmans and Francaux 1999; Poortmans et al. 2005; Robinson et al. 2000). However, these studies have been criticized by the absence of prospective randomization, the lack
of any uniform creatine source and dosage, the limited
study power of the studies, and particularly the low sensitivity of the methods used to evaluate glomerular Wltration
123
34
123
Placebo group
Week 12
Baseline
Week 12
Age (years)
24.2 5.0
NA
24.6 4.2
NA
37.6 4.6
NA
37.1 4.1
NA
30.7 6.1
NA
28.9 5.9
NA
BMI (kg m )
23.1 4.5
23.2 2.3
24.0 3.2
23.9 2.2
17.9 3.1
13.1 5.1
17.2 2.8
12.75 4.9*
0.83 0.06
0.82 0.09
0.83 0.05
0.82 0.07
80.1 8.2
79.9 7.2
79.9 9.6
79.2 4.2
64.1 6.1
58.2 2.3
65.1 6.5
59.4 3.1*
3.8 0.8
5.4 0.2
3.8 0.4
5.2 0.8*
Subjects were randomly assigned to receive either creatine (CR; n = 9) or placebo (PL; n = 9) in a double-blind
fashion. As the majority of creatine consumers are physically active, both groups undertook a program of moderate
intensity aerobic training for 3 months. At baseline (PRE)
and after 4 (POST 4) and 12 weeks (POST 12) subjects
underwent renal function tests. Blood samples were
obtained 48 h after the last training session from an antecubital vein following 12 h overnight fast, at all time points
(PRE, POST 4 and POST 12). Twenty-four-hour urine collection was also obtained 48 h after the last training session
at baseline and at the end of creatine supplementation. Possible diVerences in dietary intake were assessed by a 24-h
dietary recall at PRE and POST 12. The experimental
design is illustrated in Fig. 1.
Creatine supplementation protocol and blinding
The CR group received 0.3 g day1 kg1 of body weight for
the Wrst week, and 0.15 g day1 kg1 of body weight for the
next 11 weeks; the PL group was given dextrose in place of
creatine, at the same dose. During the loading phase, individuals received the supplement in four packages, with
equal content, and were instructed to ingest one supplement
package at breakfast, lunch and dinner and the fourth at
10 pm. During the maintenance phase, subjects consumed
the supplement as two equally divided doses, one during
lunch and the second during dinner. These packages were
coded so that neither the investigators nor the participants
were aware of the contents until completion of the analyses.
All subjects were instructed to dissolve the supplements,
preferably in juice, in order to mask both the low solubility
of creatine and the taste of dextrose. The compliance to creatine supplementation was monitored weekly by personal
communication. The subjects completed a weekly questionnaire, adapted from Volek et al. 2000, to ascertain any possible adverse eVects of creatine supplementation.
35
In order to verify the purity of the creatine used, a sample was analyzed by HPLC. This established 99.9% of
purity, with no other peaks detected (creatinine, dicyandiamide and cyclocreatine < 0.01%).
VO2peak test
Peak oxygen uptake capacity was determined at the start
of the study using a treadmill exercise test (Bruce et al.
1973). This test is conducted in 3 min stages. The Bruce
protocol starts at 4.6 METS of work, at a speed of 2.7 km/
h and a grade of 10 degrees. Every 3 min, the workload is
increased by a combination of increasing speed and the
gradient of the treadmill. VO2peak was obtained when two
of three criteria were met, namely a plateau in VO2, a
respiratory exchange ratio (RER) > 1.1, and volitional
exhaustion.
Exercise training protocol
The exercise training protocol has been described previously (Gualano et al. 2008). BrieXy, both groups were submitted to aerobic training, three times a week, for 40 min
per session, for 3 months. Running intensity was set at the
heart rate corresponding to 70% of VO2peak. Subjects were
requested to run at the pre-set heart rate during the whole of
the training session. Thus, the total amount of exercise
undertaken during training increased in both running distance and intensity in response to the training. All sessions
were monitored by a Wtness-professional. From the outset it
was ruled that subjects would be dropped from the study if
they missed three non-consecutives training sessions, or
two consecutives sessions. One subject from the PL group
was excluded for this reason.
Food intake assessment
Food intake was assessed by means of three 24-h dietary
recalls undertaken on separate days (2 weekdays and
1 weekend day) using a visual aid photo album of real
foods. The 24-h dietary recall consists of the listing of
foods and beverages consumed during 24 h prior to the
recall. The interviews were conducted face to face by a
trained dietitian, using the multiple-pass method developed
by USDA (Conway et al. 2004). Energy and macronutrient
intakes were analyzed by the Brazilian software, Virtual
Nutri, based on Handbook number 8 of the USDA Human
Nutrition Information Service (Composition of food: raw;
processed; prepared, series 116, revised 19761986).
Additional information was obtained from the Brazilian
Table of Food Composition (version 1.0, 1997, University
of So Paulo, Sao Paulo, SP). The nutrient database was
complete for all the nutrients studied.
123
36
Statistical analysis
Renal parameters were tested by a two-way ANOVA
(mixed model) with repeated measures. Group (CR and PL)
and time (pre, 4 and 12 weeks) were considered Wxed factors and subjects were deWned as a random factor. A post
hoc test adjusted by Tukey was used for multicomparison
purposes. Baseline characteristics between groups were
compared using Students t test for unpaired data. SigniWcance level was set at P < 0.05. Data are presented as
mean standard deviation. SAS proc IML was used to
perform a simulation to determine the power of the statistical tests (Ugrinowitsch et al. 2004) as suggested by Littell
et al. (2006). Expected means and variance were used as
input to simulate cystatin C data using an autoregressive
correlation structure within subjects measurements. Nine
subjects produced a power of 0.95 in the comparison
between groups for cystatin C, the most important dependent variable.
Results
The number of subjects recruited to the study is shown in
Fig. 2. Of the 103 people who responded to the initial
request for volunteers, 81 were excluded because they
performed regular physical activity or expressed selfreported chronic disease. The remaining 22 subjects were
randomly assigned to the CR or PL groups. Four subjects
were subsequently lost: three withdrew for personal reasons (two in CR and one in PL) and one was excluded
because they missed two consecutive training sessions
(PL). The compliance to creatine or placebo supplementation was 100%.
123
37
CR group
PL group
PRE
POST 12
PRE
POST 12
Energy (kcal)
2728 238
2833 201
2844 201
2899 287
Protein (%)
28.0 4.3
30.0 3.1
29.8 4.3
31.1 3.9
Lipid (%)
25.5 4.9
24.5 4.5
24.9 4.1
26 3.1
Carbohydrate (%)
46.3 3.9
43.3 5.3
45.3 4.9
42.9 5.1
1.1 0.3
1.2 0.3
1.1 0.2
1.2 0.3
Discussion
The aim of the study was to investigate the eVects of creatine supplementation on renal function in sedentary healthy
males submitted to aerobic training. To our knowledge, this
is the Wrst randomized, double-blind, placebo-controlled
trial to demonstrate that high-dose long-term creatine supplementation (10 g over 3 months) does not impair renal
function in healthy subjects, initially sedentary but undergoing a period of moderate training. In addition, we believe
that this is the Wrst study to use cystatin C as a marker of
GFR in humans supplemented with creatine.
The eVects of creatine supplementation on renal function
have been intensely discussed in the literature. Some case
123
38
clearance in creatine supplemented rats. Thus, further studies need to be conducted in order to determine the diagnostic eYcacy of cystatin C when compared with other
established markers.
Serum creatinine was signiWcantly lower in PL than in
CR subjects after creatine supplementation, which might
suggest renal function impairment. However, in contrast
cystatin C was reduced in both groups, which suggests otherwise. The higher concentrations of serum creatinine in the
CR group are most probably a reXection of the increase in
tissue creatine levels brought about by creatine supplementation, and the non-enzymic Wrst-order conversion of this to
creatinine at the rate of 1.7% per day (Wyss and Kaddurah-Daouk 2000; Pline and Smith 2005). A similar conclusion was reached by Taes et al. (2003).
However, the eVect of creatine supplementation on renal
function remains controversial even in controlled studies in
rats, which used established methods to evaluate GFR. Taes
et al. (2003) failed to demonstrate any deleterious eVects in
rats with either renal failure or normal renal function. In
contrast, Ferreira et al. (2005) suggested that creatine supplementation induced renal dysfunction in sedentary
healthy rats. In the latter study, the authors believed that
renal impairment was provoked by creatine-induced vasoconstriction and/or cytotoxic compounds. Unfortunately,
only Taes et al. 2003 reported the purity of the creatine
administered. Hence, trace contaminants associated with
the creatine could also have been partially responsible for
the opposing Wndings in the literature. In the present study,
creatine purity was assessed by HPLC and no trace contaminants were found.
Notwithstanding the observations made in rats, the relevance of these results to humans which routinely encounter
creatine in the diet is also open to question. As noted earlier
the typical non-vegetarian diet may contain 12 g creatine
(expressed as the monohydrate) daily, reaching a maximum
of 57 g. Still higher levels are found in the diets of carnivorous animals of equivalent body weight. It would be surprising if, given the span of human evolution, some
adaptation to creatine intake had not occurred. Indeed the
rapid and complete absorption of creatine supplied in the
diet (Harris et al. 1992, 2002), in contrast to the lack of
absorption in a herbivorous animal such as the horse
(Sewell and Harris 1995), suggests that adaptation has
occurred at least at one level. The elegant study conducted
by Tarnopolsky et al. (2003) highlighted the species- and
tissue-speciWc response to creatine intake. These authors
demonstrated that creatine administration can induce
chronic hepatitis in mice, but not in rats. Interestingly, neither the mice nor rats showed renal dysfunction after longterm supplementation, supporting our Wndings.
Another relevant Wnding of this study refers to the eVects
of exercise training per se on renal function. We observed
123
References
Bruce RA, Kusumi F, Hosmer D (1973) Maximal oxygen intake and
nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 85:546562
Conway JM, Ingwersen LA, Moshfegh AJ (2004) Accuracy of dietary
recall using the USDA Wve-step multiple-pass method in men: an
observational validation study. J Am Diet Assoc 104:595603
Dharnidharka VR, Kwon C, Stevens G (2002) Serum cystatin C is
superior to serum creatinine as a marker of kidney function: a
meta-analysis. Am J Kidney Dis 40:221226
Edmunds JW, Jayapalan S, DiMarco NM, Saboorian MH, Aukema
HM (2001) Creatine supplementation increases renal disease progression in Han:SPRD-cy rats. Am J Kidney Dis 37:7378
Ferreira LG, De Toledo Bergamaschi C, Lazaretti-Castro M, Heilberg
IP (2005) EVects of creatine supplementation on body composition and renal function in rats. Med Sci Sports Exerc 37:1525
1529
Finkelstein J, Joshi A, Hise MK (2006) Association of physical activity
and renal function in subjects with and without metabolic syndrome: a review of the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 48:372382
Fried LF, Orchard TJ, Kasiske BL (2001) EVect of lipid reduction on
the progression of renal disease: a meta-analysis. Kidney Int
59:260269
Gaede P, Poulsen HE, Parving HH, Pedersen O (2001) Double-blind,
randomised study of the eVect of combined treatment with vita-
39
min C and E on albuminuria in Type 2 diabetic patients. Diabet
Med 18:756760
Groeneveld GJ, Beijer C, Veldink JH, Kalmijn S, Wokke JH, van den
Berg LH (2005) Few adverse eVects of long-term creatine supplementation in a placebo-controlled trial. Int J Sports Med 26:307
313
Gualano B, Novaes RB, Shimuzu HM, Artioli GG, Rogeri PS, Ugrinowitsch C, Seguro AC, Lancha AH Jr (2006) Aerobic training
improves renal function and decreases oxidative stress in healthy
sedentary males, despite high-dose creatine supplementation. J
Am Soc Nephrol 203A
Gualano B, Novaes RB, Artioli GG, Freire TO, Coelho DF, Scagliusi
FB, Rogeri PS, Roschel H, Ugrinowitsch C, Lancha AH Jr (2008)
EVects of creatine supplementation on glucose tolerance and insulin sensitivity in sedentary healthy males undergoing aerobic
training. Amino Acids (in press)
Harris RC, Nevill M, Harris DB, FallowWeld JL, Bogdanis GC, Wise
JA (2002) Absorption of creatine supplied as a drink, in meat or
in solid form. J Sports Sci 20:147151
Harris RC, Soderlund K, Hultman E (1992) Elevation of creatine in
resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci (Lond) 83:367374
Jaber BL, Madias NE (2005) Progression of chronic kidney disease:
can it be prevented or arrested?. Am J Med 118:13231330
Kazama JJ, Kutsuwada K, Ataka K, Maruyama H, Gejyo F (2002) Serum cystatin C reliably detects renal dysfunction in patients with
various renal diseases. Nephron 91:1320
Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW,
Striker G (1994) The eVects of dietary protein restriction and
blood-pressure control on the progression of chronic renal disease. ModiWcation of diet in Renal Disease Study Group. N Engl
J Med 330:877884
Koshy KM, Griswold E, Schneeberger EE (1999) Interstitial nephritis
in a patient taking creatine. N Engl J Med 340:814815
Kreider RB (2003) Species-speciWc responses to creatine supplementation. Am J Physiol Regul Integr Comp Physiol 285:R725R726
Kreider RB, Melton C, Rasmussen CJ, Greenwood M, Lancaster S,
Cantler EC, Milnor P, Almada AL (2003) Long-term creatine
supplementation does not signiWcantly aVect clinical markers of
health in athletes. Mol Cell Biochem 244:95104
Kuehl K, Goldberg L, Elliot D (1998) Renal insuYciency after creatine
supplementation in a college football athlete (abstract). Med Sci
Sports Exerc 30:S235
Kuehl K, Goldberg L, Elliot D (2000) Re: long-term oral creatine supplementation does not impair renal function in healthy athletes.
Med Sci Sports Exerc 32:248249
Littell RC, Milliken GA, Stroup WW, WolWnger RD, Schabenberger
O (2006) SAS system for mixed models. SAS Institute, Cary
Pline KA, Smith CL (2005) The eVect of creatine intake on renal function. Ann Pharmacother 39:10931096
Poortmans JR, Auquier H, Renaut V, Durussel A, Saugy M, Brisson
GR (1997) EVect of short-term creatine supplementation on renal
responses in men. Eur J Appl Physiol Occup Physiol 76:566567
Poortmans JR, Francaux M (1999) Long-term oral creatine supplementation does not impair renal function in healthy athletes. Med
Sci Sports Exerc 31:11081110
Poortmans JR, Kumps A, Duez P, Fofonka A, Carpentier A, Francaux
M (2005) EVect of oral creatine supplementation on urinary
methylamine, formaldehyde, and formate. Med Sci Sports Exerc
37:17171720
Preiss DJ, Godber IM, Lamb EJ, Dalton RN, Gunn IR (2007) The
inXuence of a cooked-meat meal on estimated glomerular Wltration rate. Ann Clin Biochem 44:3542
Pritchard NR, Kalra PA (1998) Renal dysfunction accompanying oral
creatine supplements. Lancet 351:12521253
123
40
Robinson TM, Sewell DA, Casey A, Steenge G, GreenhaV PL (2000)
Dietary creatine supplementation does not aVect some haematological indices, or indices of muscle damage and hepatic and renal
function. Br J Sports Med 34:284288
Roos JF, Doust J, Tett SE, Kirkpatrick CM (2007) Diagnostic accuracy
of cystatin C compared to serum creatinine for the estimation of
renal dysfunction in adults and children-a meta-analysis. Clin
Biochem 40:383391
Sewell DA, Harris RC (1995) EVect of creatine supplementation in the
Thoroughbred horse. Equine Vet J 18:239242
Shao A, Hathcock JN (2006) Risk assessment for creatine monohydrate. Regul Toxicol Pharmacol 45:242251
Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL
(2003) Lifestyle factors, obesity and the risk of chronic kidney
disease. Epidemiology 14:479487
Stevens LA, Coresh J, Greene T, Levey AS (2006) Assessing kidney
function-measured and estimated glomerular Wltration rate. N
Engl J Med 354:24732483
Taes YE, Delanghe JR, Wuyts B, van de Voorde J, Lameire NH (2003)
Creatine supplementation does not aVect kidney function in an
animal model with pre-existing renal failure. Nephrol Dial Transplant 18:258264
123